Alligator Bioscience Awarded New Patent for its Protein Optimization Technology FIND in Japan

03-Dec-2009 - Sweden

Alligator Bioscience AB announces that the Japan Patent Office has granted the patent application JP 2004-506491 for its protein optimization platform, FIND® (Fragment Induced Diversity). With this patent Alligator Bioscience will have coverage for it's methods in all major markets. The newly-granted patent describes methods of optimization of protein properties and functionalities by in vitro evolution using recombination of single stranded DNA.

"The newly-granted patent in Japan confirms the strength of our expanding portfolio." said Gun-Britt Fransson, chief executive officer of Alligator Bioscience. "The patent covers the core of our company, our proprietary FIND® technology. This platform enables us to build a competitive pipeline of novel and improved versions of biopharmaceuticals. We focus on candidates in inflammation and cancer and our disclosed programs targets the C5a receptor (C5aR), Interleukin 1 (IL-1) and Interleukin 23 (IL-23). We believe this patent will be of crucial importance for our future development on the Japanese market."

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances